导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.60% | 1362/4773 |
| 近一周 | 0.79% | 55/5462 |
| 近一月 | 5.67% | 50/5421 |
| 近一季 | 5.79% | 253/5209 |
| 近半年 | 7.12% | 636/4920 |
| 近一年 | 4.39% | 1729/4366 |
| 近两年 | 40.76% | 1856/2954 |
| 近三年 | 49.43% | 546/2253 |
| 成立以来 | 59.09% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.64% 2848/4961 |
-7.71% 3796/5312 |
- - |
- - |
| 2025 | 10.45% 2813/4813 |
2.58% 1324/3635 |
11.65% 145/4076 |
-8.54% 4048/4524 |
5.44% 445/4813 |
| 2024 | 38.36% 41/3463 |
10.01% 83/2808 |
6.85% 123/3014 |
11.86% 2453/3129 |
5.22% 621/3463 |
| 2023 | -1.57% 521/2656 |
-2.17% 1932/2280 |
2.22% 153/2385 |
4.94% 111/2515 |
-6.20% 1665/2655 |
| 2022 | -3.99% 75/2207 |
2.26% 62/1919 |
-1.20% 1689/2016 |
-7.95% 154/2113 |
3.25% 739/2208 |
| 2021 | 4.25% 586/1822 |
10.84% 28/1255 |
-0.13% 1130/1330 |
-5.51% 816/1466 |
-0.32% 1223/1822 |
| 2020 | 6.44% 874/1250 |
-11.73% 848/1028 |
3.82% 928/1067 |
5.13% 928/1164 |
10.47% 594/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 华夏中证银行ETF联接A VS. 长安沪深300非周期A(740101) |